Accelerate Fund IV invests in Northernmost to improve transplant outcomes

Edmonton, AB, April 4, 2025 – Accelerate Fund IV today announced its investment in Northernmost, an Edmonton-based medical device company developing a machine to preserve and transport donor kidneys for transplant. Participants in the $2.7 million seed round include National Kidney Foundation (US), Leva Capital, Threshold Impact and Startup TNT.

Founded by Ron Mills and Daniel Salamon, Northernmost aims to revolutionize organ preservation with the NoMo™ Kidney Pump, a next-generation perfusion machine. Unlike conventional ice coolers, NoMo’s compact design continuously circulates preservation fluid through the kidney, reducing organ damage and enabling transport over greater distances. 

“We’re thankful for this vital support,” said Ron Mills, CEO of Northernmost. “And we’re proud to have earned the very first investment from Accelerate Fund IV.”

With kidneys being the most commonly transplanted organ, NoMo will increase the number of viable donor kidneys, improve transplant success rates, and potentially save healthcare payers tens of billions of dollars over the next decade. While initially focused on kidneys, the machine is anticipated to be adaptable for other transplant organs in the future.

“Northernmost represents exactly the kind of health innovation we’re excited to support – combining strong commercial potential with meaningful societal impact,” said Arden Tse, Investment Manager, Accelerate Fund. “They have a strong team addressing a clear need in the market, with regulatory and economic pressures driving the need for their solution. We look forward to seeing them hit their milestones to trigger their next capital raise to further their growth and impact millions of lives.”

This investment will enable Northernmost to complete product development with Bennu Engineering and establish manufacturing operations with Mountain Integrated in Edmonton. The company will preview the NoMo Kidney Pump to potential customers and industry experts at the Association of Organ Procurement Organizations (AOPO) Annual Meeting in June and the World Transplant Congress in August.

About Northernmost

Northernmost Medical Devices, Inc., is a Canadian startup developing machines to preserve and transport donor organs for transplant. Based in Edmonton, Alberta, with a planned US hub in Denver, the company is led by the people who designed, built, and commercialized today’s market-dominant kidney transporter.
northernmost.ca

About Accelerate Fund IV 

Accelerate Fund IV is an early-stage co-investment fund that invests in Alberta-based pre-series A companies that are focused on life sciences, digital transformation and artificial intelligence and other emerging opportunities. We co-invest in financing rounds alongside angel investors, family funds and foundations and will typically invest up to $500,000 on the same terms and conditions as private investors. Alberta Enterprise Corporation is Accelerate Fund IV’s lead limited partner. If you are a private Alberta company with proprietary technology, some customer traction and revenue, and more than half of your employees based here, consider us as a potential investor.
acceleratefund.ca

Media Inquiries:
Accelerate Fund IV
Jen Schultz
Material Insight
403.975.0241
jen @ materialinsight.com